CURASIGHT A/S |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.5 DKK | +5.00% |
|
+5.63% | -40.85% |
| 04-16 | Curasight A/S Announces Approval of Clinical Trial Application for Phase 2 Trial with uTRACE in Prostate Cancer Patients | CI |
| 04-12 | Curasight A/S Announces Board Changes | CI |
- Stock Market
- Equities
- CURAS Stock
- News Curasight A/S
- Analyst Reco.
